期刊
JOURNAL OF CONTROLLED RELEASE
卷 190, 期 -, 页码 82-93出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2014.05.004
关键词
Organ-on-a-chip; Drug delivery; Nanoparticle; Drug screening; Toxicity
资金
- Office of Naval Research Young National Investigator Award
- National Institutes of Health [HL092836, DE019024, EB012597, AR057837, DE021468, HL099073, EB008392]
- Presidential Early Career Award for Scientists and Engineers (PECASE)
- Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/51679/2011]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/51679/2011] Funding Source: FCT
Novel microfluidic tools allow new ways to manufacture and test drug delivery systems. Organ-on-a-chip systems - microscale recapitulations of complex organ functions - promise to improve the drug development pipeline. This review highlights the importance of integrating microfluidic networks with 3D tissue engineered models to create organ-on-a-chip platforms, able to meet the demand of creating robust preclinical screening models. Specific examples are cited to demonstrate the use of these systems for studying the performance of drug delivery vectors and thereby reduce the discrepancies between their performance at preclinical and clinical trials. Wealso highlight the future directions that need to be pursued by the research community for these proof-of-concept studies to achieve the goal of accelerating clinical translation of drug delivery nanoparticles. (C) 2014 Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据